Biblio

Export 629 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study., J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
H. - L. Wang, Wang, Y. - Y., Liu, X. - G., Kuo, S. - H., Liu, N., Song, Q. - Y., and Wang, M. - W., Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 51, no. 1, pp. 45-55, 2016.
X. Zhang, Cai, X., Shi, X., Zheng, Z., Zhang, A., Guo, J., and Fang, Y., Chronic Obstructive Pulmonary Disease as a Risk Factor for Cognitive Dysfunction: A Meta-Analysis of Current Studies., J Alzheimers Dis, vol. 52, no. 1, pp. 101-11, 2016.
H. Qiu, Zhong, R., Liu, H., Zhang, F., Li, S., and Le, W., Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice., J Alzheimers Dis, vol. 50, no. 3, pp. 669-85, 2016.
K. R. LeVault, Tischkau, S. A., and Brewer, G. J., Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
D. A. Nation, Tan, A., Dutt, S., McIntosh, E. C., Yew, B., Ho, J. K., Blanken, A. E., Jang, J. Yun, Rodgers, K. E., and Gaubert, A., Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion., J Alzheimers Dis, vol. 61, no. 1, pp. 91-101, 2018.
L. Wang, Qiao, Y., Zhang, H., Zhang, Y., Hua, J., Jin, S., and Liu, G., Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank., J Alzheimers Dis, vol. 73, no. 2, pp. 609-618, 2020.
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study., J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
T. Särkämö, Laitinen, S., Numminen, A., Kurki, M., Johnson, J. K., and Rantanen, P., Clinical and Demographic Factors Associated with the Cognitive and Emotional Efficacy of Regular Musical Activities in Dementia., J Alzheimers Dis, vol. 49, no. 3, pp. 767-81, 2016.
M. Chung, Rhee, H. Young, and Chung, W. Kuu, Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients., J Alzheimers Dis, vol. 80, no. 3, pp. 941-947, 2021.
Y. - L. Chang, Yen, Y. - S., Chen, T. - F., Yan, S. - H., and Tseng, W. - Y. Isaac, Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 411-23, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes., J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
J. Cummings, Ritter, A., and Zhong, K., Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future., J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare., J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
M. Grassi, Perna, G., Caldirola, D., Schruers, K., Duara, R., and Loewenstein, D. A., A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 4, pp. 1555-1573, 2018.
I. Álvarez, Aguilar, M., González, J. Manuel, Ysamat, M., Lorenzo-Bosquet, C., Alonso, A., Tartari, J. Pablo, Romero, S., Diez-Fairen, M., Carcel, M., Pujalte, F., and Pastor, P., Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia., J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain., J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
S. G. Ryman, Yutsis, M., Tian, L., Henderson, V. W., Montine, T. J., Salmon, D. P., Galasko, D., and Poston, K. L., Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 80, no. 3, pp. 1243-1256, 2021.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests., J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
J. Cummings, Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Lebioda, K., Ginsberg, H. N., Winblad, B., Zetterberg, H., and Ray, K. K., Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial., J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score., J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
P. Martín-Jiménez, Muñoz-García, M. I., Seoane, D., Roca-Rodríguez, L., García-Reyne, A., Lalueza, A., Maestro, G., Folgueira, D., Blanco-Palmero, V. A., San Martín, A. Herrero-, Llamas-Velasco, S., Pérez-Martínez, D. A., González-Sánchez, M., and Villarejo-Galende, A., Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study., J Alzheimers Dis, vol. 78, no. 4, pp. 1367-1372, 2020.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit., J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
Y. Stern, Cognitive reserve in ageing and Alzheimer's disease., Lancet Neurol, vol. 11, no. 11, pp. 1006-12, 2012.

Pages